Publication:
Central eye movement abnormalities in patients with SMA types II and III

dc.contributor.coauthorGulec, Bade
dc.contributor.coauthorAcar, Melda
dc.contributor.coauthorOruc, Yesim
dc.contributor.coauthorAlis, Ceren
dc.contributor.coauthorTutuncu, Melih
dc.contributor.coauthorGunduz, Aysegul
dc.contributor.coauthorKara, Eyyup
dc.contributor.coauthorDeniz, Risvan
dc.contributor.coauthorOzdogan, Ahmet
dc.contributor.coauthorSavrun, Feray Karaali
dc.contributor.coauthorAdatepe, Nurten Uzun
dc.contributor.coauthorAtas, Ahmet
dc.date.accessioned2025-12-31T08:19:36Z
dc.date.available2025-12-31
dc.date.issued2025
dc.description.abstractAims: Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder characterized by progressive motor neuron degeneration, leading to symmetrical proximal weakness, bulbar dysfunction, and respiratory involvement. Although extraocular muscles (EOMs) are typically spared, there are conflicting reports regarding oculomotor abnormalities in SMA. This study aimed comprehensively to assess eye movement function in patients with SMA types II and III using videonystagmography (VNG). Methods: We included 18 SMA patients and 21 healthy subjects of similar ages and sexes. All participants underwent an otoscopic/audiological examination before the VNG recording. In VNG testing, we analyzed and compared optokinetic nystagmus (OKN), saccade parameters, and smooth pursuit movement (SPM) gain. Results: There were no statistical differences between the OKN gain and saccade velocity between groups. There was a lower percentage of saccade accuracy in the SMA group than in the control group (p = 0.017). SPM gain was lower in the SMA group than in the control group (p < 0.0001). The correlation analyses revealed a positive correlation between age and saccade latency (r = 0.613, p < 0.0001) and a negative correlation between age and SPM gain (r =-0.487, p = 0.003). Discussion: In this study, we performed a comprehensive evaluation of eye movement function with VNG in patients with SMA. Our findings indicate that while extraocular muscles remain unaffected in SMA, subtle central oculomotor control abnormalities-likely involving supranuclear and/or cerebellar pathways-may accompany the disease and can be quantitatively detected using VNG.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccesshybrid
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.doi10.1016/j.neucli.2025.103112
dc.identifier.eissn1769-7131
dc.identifier.embargoNo
dc.identifier.issn0987-7053
dc.identifier.issue6
dc.identifier.pubmed41092613
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-105018486166
dc.identifier.urihttps://doi.org/10.1016/j.neucli.2025.103112
dc.identifier.urihttps://hdl.handle.net/20.500.14288/31465
dc.identifier.volume55
dc.identifier.wos001598145600001
dc.keywordsSpinal muscular atrophy
dc.keywordsVideonystagmography
dc.keywordsOptokinetic nystagmus
dc.keywordsExtraocular muscle activities
dc.language.isoeng
dc.publisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofNeurophysiologie Clinique
dc.relation.openaccessNo
dc.rightsCopyrighted
dc.subjectNeurosciences & Neurology
dc.subjectPhysiology
dc.titleCentral eye movement abnormalities in patients with SMA types II and III
dc.typeJournal Article
dspace.entity.typePublication

Files